J. Cordoba et al., GLUTAMINE, MYOINOSITOL, AND ORGANIC BRAIN OSMOLYTES AFTER PORTACAVAL ANASTOMOSIS IN THE RAT - IMPLICATIONS FOR AMMONIA-INDUCED BRAIN EDEMA, Hepatology, 24(4), 1996, pp. 919-923
Brain myo-inositol, an organic osmolyte, is decreased in cirrhotic pat
ients with hepatic encephalopathy but appears unchanged in fulminant h
epatic failure. An osmoregulatory response to the increase in brain gl
utamine may explain the decrease in brain myo-inositol; if this is the
case, organic osmolytes may account for differences in the developmen
t of brain edema seen in acute or chronic liver failure. The response
of myo-inositol and nine other organic osmolytes to the increase in br
ain glutamine at different time intervals after portacaval anastomosis
(PCA) in the rat was studied. Organic osmolytes were measured in brai
n tissue and cerebrospinal fluid. Water in cerebral cortex was measure
d after ammonia infusion with the gravimetric method. Six weeks after
PCA, despite an increase in brain glutamine (PCA, 16.4 +/- 2 mmol . kg
wt(-1) . kg wt(-1); sham, 5 +/- 1 mmol . L(-1) . kg wt(-1)), the cont
ent of total organic osmolytes did not increase (PCA, 44.1 +/- 3; sham
, 43 +/- 4) because of a decrease of other osmolytes (myo-inositol, 54
%; urea, 39%; taurine, 33%; and glutamate, 8%). Brain myoinositol was
lower at 3 weeks (3.4 +/- 0.5 kg wt(-1)) than at 1 day after PCA (4.7
+/- 0.5 kg wt(-1)). An ammonia infusion resulted in brain edema at bot
h time points. In conclusion, the reduction in brain myo-inositol in P
CA rats is accompanied by the decrease of other organic osmolytes, sup
porting the view that changes in myo-inositol reflect an osmoregulator
y response. The decrease in brain myo-inositol is more marked as time
elapses after PCA In a model in which short-term and large doses of am
monia were infused, the decrease in brain myo-inositol did not prevent
the development of brain swelling. Understanding brain osmoregulatory
mechanisms may provide new insights into hepatic encephalopathy and b
rain edema in fulminant hepatic failure.